Published by
@ShahidNShah
@ShahidNShah
October 18, 2022
Online
An ageing population means an urgent need for better and effective treatment for age-related illnesses. Despite billion-dollar investments for drug development for these conditions, especially neurogenerative diseases, there is a low success rate and it is a slow process. A major challenge is the lack of clinical outcome assessments (COAs) that are sensitive and able to detect changes and treatment efficacy during clinical development. Established COAs are often subjective, providing only a snapshot of patients’ conditions. Digital health technologies (DHTs), such as wearables, can collect health-related data continuously and remotely in patients’ real lives. Deriving clinical insights from the data from such technologies could transform clinical trials and accelerate clinical development in neurodegenerative conditions.
Continue reading at ispor.org
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 23, 2024 at 3:40am